Free Trial

Royce & Associates LP Increases Stake in inTEST Co. (NYSE:INTT)

inTEST logo with Computer and Technology background
Remove Ads

Royce & Associates LP raised its position in inTEST Co. (NYSE:INTT - Free Report) by 17.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,433,099 shares of the company's stock after buying an additional 213,942 shares during the quarter. Royce & Associates LP owned about 11.58% of inTEST worth $12,310,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. XTX Topco Ltd purchased a new stake in inTEST in the 3rd quarter worth about $120,000. JPMorgan Chase & Co. increased its stake in shares of inTEST by 42.1% in the third quarter. JPMorgan Chase & Co. now owns 37,481 shares of the company's stock worth $274,000 after purchasing an additional 11,102 shares in the last quarter. Geode Capital Management LLC raised its position in shares of inTEST by 6.6% in the third quarter. Geode Capital Management LLC now owns 131,106 shares of the company's stock valued at $957,000 after purchasing an additional 8,161 shares during the period. AMH Equity Ltd lifted its stake in shares of inTEST by 1.7% during the 4th quarter. AMH Equity Ltd now owns 117,990 shares of the company's stock valued at $1,014,000 after buying an additional 1,990 shares in the last quarter. Finally, Bard Associates Inc. boosted its holdings in inTEST by 5.7% in the 4th quarter. Bard Associates Inc. now owns 210,491 shares of the company's stock worth $1,808,000 after buying an additional 11,321 shares during the period. Hedge funds and other institutional investors own 63.18% of the company's stock.

inTEST Price Performance

NYSE INTT traded up $0.01 on Friday, hitting $7.51. The stock had a trading volume of 37,884 shares, compared to its average volume of 79,666. The company has a market capitalization of $92.94 million, a price-to-earnings ratio of 32.65 and a beta of 1.90. inTEST Co. has a 52-week low of $6.28 and a 52-week high of $14.35. The firm has a 50-day moving average of $8.35 and a 200-day moving average of $7.80. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.38 and a current ratio of 2.26.

Remove Ads

inTEST (NYSE:INTT - Get Free Report) last posted its quarterly earnings data on Friday, March 7th. The company reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.14 by $0.09. inTEST had a return on equity of 5.31% and a net margin of 2.33%. During the same quarter last year, the business earned $0.16 earnings per share. Equities analysts expect that inTEST Co. will post 0.41 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. Northland Securities boosted their target price on shares of inTEST from $13.00 to $16.00 and gave the company an "outperform" rating in a report on Wednesday, January 8th. Northland Capmk raised inTEST from a "hold" rating to a "strong-buy" rating in a report on Thursday, January 2nd.

Read Our Latest Report on inTEST

inTEST Company Profile

(Free Report)

inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies.

Further Reading

Institutional Ownership by Quarter for inTEST (NYSE:INTT)

Should You Invest $1,000 in inTEST Right Now?

Before you consider inTEST, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and inTEST wasn't on the list.

While inTEST currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

HIMS Stock Up 120%! More Growth Ahead?

HIMS Stock Up 120%! More Growth Ahead?

Hims & Hers (NYSE: HIMS) has skyrocketed 120% in just a month! Is it the next big disruptor in healthcare, or is it overpriced?

Recent Videos

 5 Stocks to BUY NOW in April 2025
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads